Pilot trial demonstrates efficient production of mRNA vaccines through plasmid linearization, suggesting scalable methods for vaccine development.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Abreu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: